Regeneron Billionaires Got Raises in 2015 Before Shares Fell

Regeneron Pharmaceuticals Inc. Chief Executive Officer Leonard S. Schleifer and research chief George D. Yancopoulos, who became billionaires as the value of their company soared, saw pay raises last year.

Schleifer’s pay grew to $47.5 million, up from $42 million, according to the summary compensation table disclosed in a Tuesday proxy statement. Yancopoulos’s compensation grew to $40.3 million from $35.5 million. Most of the increases were due to more valuable option awards and bigger bonus payouts.